Avoid common mistakes on your manuscript.
1 Correction: CNS Drugs (2022) 36:659–679 https://doi.org/10.1007/s40263-022-00932-2
This article was published online on June 27, 2022. An error was subsequently identified in the article, and the following correction should be noted:
In the original publication, section 4.6, page 667, the reference cited in the first full sentence in column 2 and in Table 5 on the same page that read:
“This information can be used to optimize clozapine dosage (Table 5) [103].”
“Table 5 Therapeutic drug monitoring (TDM)-informed decision-making algorithm for clozapine-treated patientsa [103]”
“Adapted by permission from reference [103]”
Should read:
“This information can be used to optimize clozapine dosage (Table 5) [104].”
“Table 5 Therapeutic drug monitoring (TDM)-informed decision-making algorithm for clozapine-treated patientsa [104]”
“Adapted by permission from reference [104]”
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Correll, C.U., Agid, O., Crespo-Facorro, B. et al. Correction: A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia. CNS Drugs 36, 1015 (2022). https://doi.org/10.1007/s40263-022-00946-w
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40263-022-00946-w